HYDERABAD | 23 September 2026: Deepening its clinical data engineering footprint in South Asia, UK-headquartered biometrics Clinical Research Organization (CRO) Veramed has officially inaugurated a new operational facility in Hyderabad. Operating locally under its registered Indian subsidiary, Veramed Data Services Private Limited, the expansion formalizes a multi-city presence designed to scale global delivery across clinical data management, biostatistics, and statistical programming.

Rather than relocating its primary corporate base, Veramed is deploying a structured hub-and-spoke architecture across Southern India. While Bengaluru remains the company’s national headquarters and registered office, the new Hyderabad facility converts an existing cluster of remote specialists into a permanent physical nerve center within India’s premier life sciences corridor

KEY HIGHLIGHTS

  • The HITECH City Footprint: The new facility is situated within Cyber Pearl IT Park in Madhapur, HITECH City, placing the center directly inside Hyderabad’s dense pharmaceutical and technology belt.
  • Targeted Workforce Expansion: Following rapid headcount expansion over the past 24 months, Veramed’s Indian workforce is projected to grow by an additional 10% before the end of 2026, driven by immediate lateral recruitment in Hyderabad.
  • Hub-and-Spoke Governance: The Madhapur office functions as a strategic growth spoke complementing the primary headquarters on Field Marshal Cariappa Road in Bengaluru, allowing the firm to tap two distinct regional talent pools simultaneously.
  • Ecosystem Selection Drivers: Corporate leadership selected Hyderabad specifically for its concentration of life sciences universities, Domestic established CRO talent density, and transit infrastructure.
  • Leadership: The operational rollout is spearheaded by Gaurab Chakraborty, Head of Veramed India, aligning localized biometrics delivery with global standards overseen by CEO Troy McCall.

Headquartered in Twickenham, London, Veramed operates biometrics Contract Research Organization serving global pharmaceutical conglomerates and emerging biotechnology enterprises. Unlike generalist CROs that manage physical clinical clinics or wet labs, Veramed focuses strictly on the quantitative data layer of drug development, operating through both Functional Service Provider (FSP) embedded models and bespoke project-based consulting.

Holding ISO/IEC 27001:2022 information security certification and accredited as a Certified B Corporation, the firm maintains an international delivery network spanning the United Kingdom (Twickenham and Swansea), the United States (Burlington, Massachusetts), Germany (Frankfurt), Ukraine (Kyiv and Kharkiv), and India (Bengaluru and Hyderabad).

 

“

Our extraordinary teams in India truly embody everything that makes Veramed special, and it’s incredible to see them continue to grow and drive Veramed’s success. This new office represents another significant step in growing our talented, connected, and future-ready team.

– Troy McCall, Chief Executive Officer, Veramed

CAPABILITY BLUEPRINT: INSIDE THE HYDERABAD BIOMETRICS NODE

Modern drug development relies heavily on the speed and statistical integrity with which clinical trial data is cleaned, analyzed, and formatted for regulatory submission. The Hyderabad teams are mandated to execute specialized quantitative workflows supporting Phase I through Phase IV trials:

  • Biostatistics & Trial Design: Localized statisticians work alongside global biotech and pharmaceutical sponsors to structure complex clinical study designs, calculate sample parameters, and evaluate intricate therapeutic endpoints across oncology, immunology, neurology, respiratory, and rare diseases.
  • Statistical Programming & Open-Source Integration: Engineering squads utilize advanced statistical programming incorporating R, open-source frameworks, and AI-enabled automation tools to convert raw patient trial data into audit-ready Clinical Study Reports (CSRs) and regulatory submission packages.
  • Clinical Data Management: Specialist teams govern end-to-end data integrity, ensuring that multi-site clinical trial datasets meet stringent international regulatory compliance without triggering audit findings or submission delays.

Detailing the operational transition from remote teams to a physical collaboration hub, Gaurab Chakraborty, Head of Veramed India, stated:

“

The new Hyderabad office represents an exciting milestone for Veramed India and an important step in our continued growth. We have already built a strong and talented team in Hyderabad. Having a physical office will give our colleagues the opportunity to work together, collaborate, develop, and build a strong community.

– Gaurab Chakraborty, Head of Veramed India

Industry Insights

Assessing Veramed’s dual-city Indian footprint highlights two structural shifts within the global life sciences outsourcing sector:

  1. The Bengaluru-Hyderabad Biometrics Axis: While Bengaluru offers unmatched software and AI platform engineering, Hyderabad has cemented its position as India’s pharmaceutical and clinical research capital. For a biometrics CRO operating at the intersection of statistical code and clinical biology, maintaining physical hubs in both cities captures the full spectrum of computational and domain-specific talent.
  2. Consolidating Distributed Talent into Physical Hubs: : Post-pandemic, many mid-sized international service providers built remote pockets of talent across Tier-1 Indian metros. Veramed’s move into Cyber Pearl IT Park reflects a broader industry pivot: converting dispersed remote cohorts into physical offices to strengthen data governance, accelerate junior statistician mentorship, and improve employee retention.

WAY FORWARD

The formalization of Veramed’s Hyderabad facility underscores the rising strategic value of specialized clinical data talent in India. As global pharmaceutical sponsors face mounting pressure to compress drug development timelines and reduce the cost of bringing complex therapies to market, the demand for agile, high-precision statistical programming and biostatistics is intensifying.

By pairing its established Bengaluru headquarters with a dedicated physical hub in Hyderabad’s HITECH City, Veramed expands its recruitment bandwidth while insulating its global delivery pipelines against regional talent bottlenecks. Ultimately, this expansion reinforces India’s position not merely as a back-office support base, but as a primary quantitative engine validating the safety and efficacy of global medical treatments

Curated by SSF Global

Tracking the shifts shaping GCCs, enterprise ecosystems, and the future of global business.

Share on      

SSF Global is a Global Community for Enterprise Function Leaders and serves as a research & advisory platform focused on Global Business Services (GBS), Global Capability Centres (GCCs), and the evolution of enterprise innovation in India and beyond. We track, publish, and partner in narratives that shape how capability centres transform into hubs of trust, intelligence, and sustainable growth. We also evaluate, assess and benchmark the GCCs for their performance, maturity and other parameters using our proprietary tools built from the knowledge gained from direct interaction with our members (GCCs & GBS).